Latham & Watkins has advised TNG Group on the deal. TNG Group announced the acquisition of sdt.net AG. The transaction marks one of the first deals...
TNG Group’s Acquisition of sdt.net AG
Beacon Roofing Supply’s $600 Million Senior Secured Notes Offering
Sidley Austin advises Beacon, and Latham & Watkins advises the initial purchasers on the offering. Beacon Roofing Supply, Inc. (Nasdaq: BECN) has announced the pricing of...
TotalEnergies’s Investments in NextDecade and in Rio Grande LNG Project
Jones Day represented TotalEnergies, Kirkland & Ellis LLP acted as legal counsel to GIP, Sidley Austin LLP acted as legal counsel to GIC, White & Case...
Janux Therapeutics’ $60 Million Offering of Common Stock and Pre-Funded Warrants
Cooley advised Janux, and Latham & Watkins advised the underwriter on the offering. Janux Therapeutics, Inc. (Nasdaq: JANX) has announced the pricing of an underwritten offering of...
Korro Bio and Frequency Therapeutics’ Merger Agreement
Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
U.S. Sugar’s Unanimous Third Circuit Affirmance
Latham represented U.S. Sugar in the dispute. U.S. Sugar scored a major victory when the Third Circuit Court of Appeals unanimously affirmed the Delaware federal court’s September...
FC Internazionale Milano’s Extension of Nike Partnership
Latham & Watkins advised FC Internazionale Milano on the deal. FC Internazionale Milano announced the extension of the club’s longstanding partnership with Nike, one of the...
Rithm Capital’s Acquisition of Sculptor Capital Management
Skadden, Arps, Slate, Meagher & Flom LLP and Debevoise & Plimpton LLP served as legal counsel to Rithm. Latham & Watkins LLP acted as legal counsel...
Cadence’s Acquisition of Rambus PHY IP Assets
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
ODDITY Tech’s $424 Million IPO
Herzog Fox & Neeman and Latham & Watkins LLP are advising ODDITY Tech Ltd., while Davis Polk & Wardwell and Goldfarb Gross Seligman & Co. are...
4D Molecular Therapeutics’ License Agreement with Astellas Pharma
Latham & Watkins advises 4D Molecular Therapeutics on the deal. Astellas Pharma Inc. (TSE: 4503) and 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) have announced a license...
North Branch Capital’s $213 Million Fund II Formation
Latham & Watkins advised North Branch Capital in the fund raise. North Branch Capital announced the first and final close of its oversubscribed second fund, North Branch...